Search
for
Sort by
Research 31–60 of 1000+
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Evaluating Testosterone and Dehydroepiandrosterone Sulfate (DHEA-S) as Biomarkers for Male Androgenetic Alopecia
- Serum testosterone levels and clinical signs of hypogonadism in men with type 2 diabetes
- Testosterone, sex hormone-binding globulin and dehydroepiandrosterone levels and cervical length of Egyptian women with a history of recurrent miscarriages, polycystic ovary syndrome and without the conditions at three stages of pregnancy
- Reduction in the Free Androgen Index in Overweight Women After Sixty Days of a Low Glycemic Diet
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Free Androgen Index (FAI): Marker of Premature Androgenetic Alopecia in Men
- The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia
- EXPRESS: Free androgen index and its relation with female pattern hair loss
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Testosterone Supplementation for Aging-Associated Sarcopenia
- A multifunctional cholesterol-free liposomal platform based on protopanaxadiol for alopecia therapy
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Spearmint herbal tea has significant anti‐androgen effects in polycystic ovarian syndrome. a randomized controlled trial
- No evidence for the immunocompetence handicap hypothesis in male humans
- Androgen excess: Investigations and management
- Diagnosis of hyperandrogenism: Biochemical criteria
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study
- Male gonadal function in coeliac disease: 2. Sex hormones.
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Clinical Usefulness of Plasma Androstanediol Glucuronide Measurements in Women with Idiopathic Hirsutism*
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- THE TREATMENT OF HIRSUTISM WITH A COMBINATION OF DESOGESTREL AND ETHINYL OESTRADIOL
- Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: A controlled, population-based study
- Androgen insufficiency in women: diagnostic and therapeutic implications